Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 170 | 0 | 0 | 0 | 0 |
| Gross Profit | 170 | N/A | N/A | N/A | N/A |
| Operating Expenses | 18,055 | 13,009 | 10,409 | 6,951 | 2,871 |
| Operating Income | -17,885 | -13,009 | -10,409 | -6,951 | -2,871 |
| Interest Expense | 9 | 0 | 0 | 0 | 0 |
| Other Income | -215 | 234 | 521 | -95 | 82 |
| Pre-tax Income | -18,109 | -12,775 | -9,888 | -7,046 | -2,789 |
| Net Income Continuous | -18,109 | -12,775 | -9,888 | -7,046 | -2,789 |
| Net Income | $-18,109 | $-12,775 | $-9,888 | $-7,046 | $-2,789 |
| EPS Basic Total Ops | -0.76 | -0.64 | -0.52 | -0.47 | -0.22 |
| EPS Basic Continuous Ops | -0.76 | -0.64 | -0.52 | -0.47 | -0.22 |
| EPS Diluted Total Ops | -0.76 | -0.64 | -0.52 | -0.47 | -0.22 |
| EPS Diluted Continuous Ops | -0.76 | -0.64 | -0.52 | -0.47 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.76 | -0.64 | N/A | N/A | N/A |
| EBITDA(a) | $-17,483 | $-12,945 | $-10,409 | $-6,951 | $-2,871 |